Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-16

Clinical Trial Update: Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis [NA]

View source ↗

Summary

A completed clinical trial sponsored by Cairo University evaluated the effect of probiotic therapy on relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic therapy

Snippet

Sponsor: Cairo University | Conditions: Multiple Sclerosis (MS) Relapsing Remitting | NA | Status: COMPLETED